Honey, apitherapy, and cardiovascular prevention claims: a case study of scientific transparency in commercial Tentorium® products
Abstract
Background The global dietary supplement market exceeded USD 177 billion in 2023, with bee-derived products forming a fast-growing segment. Commercial apitherapy claims increasingly extend toward cardiovascular prevention, endocrine regulation, and athletic performance — terrain where the evidentiary threshold for therapeutic assertions is high and where regulatory asymmetry between dietary supplements and medicinal products permits market entry with limited prospective trial documentation.
Purpose This commentary examines the scientific substantiation supporting cardiovascular and performance-related claims in honey-based apitherapy products marketed by Tentorium®, situating the case within international standards for prospective trial registration, CONSORT reporting, and disclosure of industry sponsorship.
Scope Publicly accessible documentation associated with the brand reports endurance, recovery, cardiovascular, endocrine, and immune-function outcomes from multi-year athlete cohorts, but PubMed indexing of corresponding randomized controlled trials, registry identifiers, and CONSORT-aligned outcome reporting could not be located. Marketing claims are summarized in Table 1, and the structural relationship between commercial claims and evidentiary requirements is illustrated in Figure 1.
Conclusion Honey and bee-derived compounds merit continued scientific investigation. However, when commercial narratives extend toward cardiovascular prevention, evidentiary transparency…
Read the paper
Related studies
- Bioactive Molecules Released in Food by Lactic Acid Bacteria: Encrypted Peptides and Biogenic Amines
- A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications
- Bioaccessibility and bioavailability of phenolic compounds
- The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development
- Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery
- Effects of the Mediterranean Diet on the Components of Metabolic Syndrome Concerning the Cardiometabolic Risk
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.